Technology Innovation Institute Appoints Eminent Technologist Dr Ray O. Johnson as CEO
2.8.2021 16:54:00 EEST | Business Wire | Press release
Technology Innovation Institute (TII), the applied research pillar of the Advanced Technology Research Council (ATRC), the overarching advanced technology body in Abu Dhabi responsible for driving research and development for transformative technology outcomes, today announced the appointment of veteran technologist and entrepreneur Dr Ray O. Johnson as Chief Executive Officer. Dr Johnson will work on shaping the strategic direction of the Institute and lead the execution of its growth strategies to achieve operational excellence.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210802005462/en/
Dr Ray O. Johnson, Chief Executive Officer, Technology Innovation Institute (Photo: AETOSWire)
Prior to joining TII, Dr Johnson was an Operating Partner at Bessemer Venture Partners, a top-tier American venture capital company that has been part of 130 IPOs in the last 50 years, and before that, he was the Corporate Senior Vice President for Engineering, Technology, and Operations and Chief Technology Officer of the Lockheed Martin Corporation.
Dr Johnson brings to his role over four decades of experience in global technology leadership, making strategic investments in disruptive technologies, and developing business strategies that resulted in several new billion-dollar lines of business. He also holds outstanding networking capabilities; he has met with leaders at the highest echelons of government, industry, and academia. He is frequently sought after as a speaker at global forums on business, strategy, innovation, and education.
Speaking on the new appointment, His Excellency Faisal Al Bannai, Secretary General of ATRC, said: “We welcome Dr Ray Johnson as the first CEO of Technology Innovation Institute. His appointment is a much anticipated one – we were keen that the person entrusted with this role should not merely be an excellent research and technology specialist, but equally, a consummate professional and industry stakeholder that is capable of ensuring the most positive outcomes for the breakthrough projects TII is currently engaged in across its seven initial dedicated research centres.
“We are confident Dr Johnson will be able to build game-changing synergies for TII as he leads it towards realising its wider goals of growing its talented global team of 375+ researchers, scientists, and engineers, and ensuring the objectives of the current workstreams are met. He will also leverage his vast network to further expand our visibility and reach across markets.”
For his part, Dr Ray O. Johnson said: “I am very excited about this new role in a region that I admire for its dedication to advanced research and development for the betterment of the UAE. Since TII’s inception in November 2020, I have followed its many announcements and achievements with great interest. As it moves into a new phase of growth, I look forward to working with the talented teams of researchers across its centres to drive competitive results and facilitate breakthrough solutions that transition to the market.”
Technology Innovation Institute (TII) is a pioneering global research and development centre that focuses on applied research and new-age technology capabilities. The Institute has seven initial dedicated research centres in quantum, autonomous robotics, cryptography, advanced materials, digital security, directed energy, and secure systems. By working with exceptional talent, universities, research institutions and industry partners from all over the world, the Institute connects an intellectual community and contributes to building an R&D ecosystem in Abu Dhabi and the UAE, reinforces the status of Abu Dhabi and the UAE as a global hub for innovation, and contributes to the broader development of the knowledge-based economy.
For information on Advanced Technology Research Council (ATRC), visit www.atrc.ae
For information on Technology Innovation Institute (TII), visit www.tii.ae
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210802005462/en/
Contact information
Technology Innovation Institute
Hanz Valbuena
hanz.valbuena@tii.ae
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
REVEAL GENOMICS Aligns Founder Leadership With Priorities to Support Long-term Growth, Scientific Excellence, and Global Partnerships27.1.2026 14:43:00 EET | Press release
REVEAL GENOMICS, a Barcelona-based biotechnology company that advances precision oncology through biomarker innovation, today announced a strengthened leadership framework with several senior appointments. These appointments underscore the company’s commitment to scientific excellence, technological rigor, and clinical impact, and they seek to support the continued development, validation, and global adoption of the company’s genomic assays. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260127015446/en/ The company appoints Ana Vivancos, Ph.D., as Director of NGS and Genomic Technologies; Joel Parker, Ph.D., as Chief Scientific Officer; and Aleix Prat, M.D., Ph.D., as Chairman of the Board of Directors. The roles are assumed by co-founders of REVEAL GENOMICS and are a reflection of the company’s strong internal leadership, continuity of vision, and long-term commitment to its scientific and clinical mission. By aligning its
Bial Achieves Key Milestone in Phase 2b ACTIVATE Study of BIA 28-6156 in GBA1-Associated Parkinson’s Disease27.1.2026 13:00:00 EET | Press release
Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that 75% of patients currently enrolled in its ongoing Phase 2b clinical study ACTIVATE (ClinicalTrials.gov identifier: NCT05819359) have completed the double-blind treatment period through week 78. This operational milestone represents a significant step toward the completion of the ACTIVATE study, which is evaluating the efficacy, safety, tolerability, pharmacodynamics, and pharmacokinetics of BIA 28-6156 in patients with Parkinson’s disease (PD) who have a pathogenic mutation in the glucocerebrosidase 1 (GBA1) gene (GBA-PD). The date of the Last Patient, Last Visit (LPLV) is anticipated in April 2026, with topline results on track to be released in mid-2026. “We look forward to presenting data from our Phase 2b study. BIA 28-6156 is the leading asset in GBA-PD, and clinical outcomes are just around the corner,” said António Portela, CEO of Bial. “We are witnessing growing
Libraesva and Cyber Guru Announce Strategic Combination to Create a Leading European Human-Centric Cybersecurity Provider27.1.2026 12:00:00 EET | Press release
Cyber Guru and Libraesva today announced a strategic combination that brings together two highly complementary Italian cybersecurity companies to form a new European leader in human-centric cyber protection. The combined group will offer organisations an integrated approach to defending against email-based threats, social engineering, and human-targeted attacks, integrating advanced technology with behavioural resilience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260127531600/en/ Cyber threats are evolving rapidly, with attackers focusing less on infrastructure and more on the weak link in security – human behaviour. Phishing, business email compromise, smishing, QR-code attacks, social engineering and many other forms of attacks targeting humans continue to be primary breach vectors and are rapidly growing in sophistication with support of widely available AI tools. By integrating Libraesva’s advanced, privacy-first em
Europe’s First Meteorological Infrared Sounder Reveals the Atmosphere in 3D27.1.2026 11:30:00 EET | Press release
The first images from Europe’s pioneering meteorological infrared sounder were unveiled today at the EU Space Conference in Brussels, marking a major advance in the ability to monitor how the atmosphere evolves before and during severe weather. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260127490399/en/ Full Earth disc image from the MTG-S Infrared Sounder showing a surface-temperature-sensitive channel, captured between 12:45 and 15:30 UTC on 15 November 2025. The image distinguishes land and sea surface temperatures as well as cloud-top temperatures, highlighting cloud structures and weather systems. Hot desert regions appear in red, while cold cloud tops are shown in blue. © Image: Data acquired on 15 November 2025 and processed by industrial partners Thales and OHB under the supervision of EUMETSAT and ESA. Visual produced by EUMETSAT. The images were captured by the Infrared Sounder (IRS) flying aboard Meteosat Thir
Clearwater Analytics Embeds AI into Beacon Risk Platform to Accelerate Model Validation and Exposure Analysis27.1.2026 11:00:00 EET | Press release
Clearwater Analytics(NYSE: CWAN), the most comprehensive technology platform for investment management, today announced breakthrough embedded agentic AI capabilities within Beacon by CWAN, its enterprise risk and quantitative analytics platform, enabling risk teams to accelerate model validation, exposure analysis, and decision-making. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126906084/en/ As regulatory scrutiny intensifies and portfolio complexity reaches unprecedented levels, traditional risk platforms are failing institutional investors when they need answers most. Built specifically for quantitative developers and risk professionals managing complex institutional portfolios, CWAN’s embedded AI operates within Beacon’s calculation engine itself, training the agents our clients deploy on data grounded in a firm’s actual positions, validated models, and real-time calculations. This breakthrough architecture process
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom